October 16, 2019 / 5:12 AM / a month ago

CORRECTED-Roche boosts 2019 sales outlook again, sees Spark deal this year

(Corrects sales target to high-single digit range, from mid- to high-single digits.)

ZURICH, Oct 16 (Reuters) - Swiss drugmaker Roche on Wednesday boosted its 2019 sales outlook for the third time and said it still expects to complete its $4.3 billion takeover of gene therapy specialist Spark Therapeutics this year.

"Sales are now expected to grow in the high-single digit range, at constant exchange rates," the company said in a statement. (Reporting by John Miller; editing by Thomas Seythal)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below